117 related articles for article (PubMed ID: 18316259)
1. Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats.
Tian XY; Zhang Q; Zhao R; Setterberg RB; Zeng QQ; Iturria SJ; Ma YF; Jee WS
Bone; 2008 May; 42(5):914-20. PubMed ID: 18316259
[TBL] [Abstract][Full Text] [Related]
2. Continuous infusion of PGE2 is catabolic with a negative bone balance on both cancellous and cortical bone in rats.
Tian XY; Zhang Q; Zhao R; Setterberg RB; Zeng QQ; Ma YF; Jee W SS
J Musculoskelet Neuronal Interact; 2007; 7(4):372-81. PubMed ID: 18094515
[TBL] [Abstract][Full Text] [Related]
3. Effects of daily administration of prostaglandin E2 and its withdrawal on the lumbar vertebral bodies in male rats.
Ke HZ; Jee WS
Anat Rec; 1992 Oct; 234(2):172-82. PubMed ID: 1416104
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat.
Li CY; Jee WS; Chen JL; Mo A; Setterberg RB; Su M; Tian XY; Ling YF; Yao W
Calcif Tissue Int; 2003 Jan; 72(1):42-9. PubMed ID: 12370795
[TBL] [Abstract][Full Text] [Related]
5. Alfacalcidol-stimulated focal bone formation on the cancellous surface and increased bone formation on the periosteal surface of the lumbar vertebrae of adult female rats.
Chen H; Tian X; Liu X; Setterberg RB; Li M; Jee WS
Calcif Tissue Int; 2008 Feb; 82(2):127-36. PubMed ID: 18175034
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease.
Desimone DP; Greene VS; Hannon KS; Turner RT; Bell NH
J Bone Miner Res; 1993 May; 8(5):625-34. PubMed ID: 8511990
[TBL] [Abstract][Full Text] [Related]
7. Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats.
Zhou H; Ma YF; Yao W; Cui L; Setterberg R; Liang CT; Jee WS
Calcif Tissue Int; 2001 Mar; 68(3):179-84. PubMed ID: 11351502
[TBL] [Abstract][Full Text] [Related]
8. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
Seeman E
Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
[TBL] [Abstract][Full Text] [Related]
9. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
[TBL] [Abstract][Full Text] [Related]
10. Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats.
Ma YF; Li XJ; Jee WS; McOsker J; Liang XG; Setterberg R; Chow SY
Bone; 1995 Dec; 17(6):549-54. PubMed ID: 8835309
[TBL] [Abstract][Full Text] [Related]
11. 1 Alpha-hydroxyvitamin D2 and 1 alpha-hydroxyvitamin D3 have anabolic effects on cortical bone, but induce intracortical remodeling at toxic doses in ovariectomized rats.
Weber K; Kaschig C; Erben RG
Bone; 2004 Sep; 35(3):704-10. PubMed ID: 15336607
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of vitamin K2 and prostaglandin E2 on cancellous bone mass in hypophysectomized young rats.
Iwamoto J; Takeda T; Sato Y; Yeh JK
Calcif Tissue Int; 2006 Nov; 79(5):318-25. PubMed ID: 17048065
[TBL] [Abstract][Full Text] [Related]
13. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
[TBL] [Abstract][Full Text] [Related]
14. Loss of prostaglandin E2-induced extra cortical bone after its withdrawal in rats.
Jee WS; Ke HZ; Li XJ
Bone Miner; 1992 Apr; 17(1):31-47. PubMed ID: 1581704
[TBL] [Abstract][Full Text] [Related]
15. Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain.
Yao W; Jee WS; Zhou H; Lu J; Cui L; Setterberg R; Liang T; Ma Y
Bone; 1999 Dec; 25(6):697-702. PubMed ID: 10593415
[TBL] [Abstract][Full Text] [Related]
16. Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs.
Li XJ; Jee WS; Li YL; Patterson-Buckendahl P
Bone; 1990; 11(5):353-64. PubMed ID: 2252812
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of orchidectomy and sciatic neurectomy on cortical and cancellous bone in young growing rats.
Iwamoto J; Takeda T; Ichimura S; Sato Y; Yeh JK
J Bone Miner Metab; 2003; 21(4):211-6. PubMed ID: 12811625
[TBL] [Abstract][Full Text] [Related]
18. Rapid improvements in cortical bone dynamics and structure after lactation in established breeder rats.
Miller SC; Bowman BM
Anat Rec A Discov Mol Cell Evol Biol; 2004 Feb; 276(2):143-9. PubMed ID: 14752853
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats.
Jee WS; Mori S; Li XJ; Chan S
Bone; 1990; 11(4):253-66. PubMed ID: 2242291
[TBL] [Abstract][Full Text] [Related]
20. Trabecular and endocortical bone surfaces in the rat: modeling or remodeling?
Erben RG
Anat Rec; 1996 Sep; 246(1):39-46. PubMed ID: 8876822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
